Cargando…
Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer
BACKGROUND: Amplifications at 6p22.3 are prevalent in advanced stage bladder cancer (TCC). Previous studies have identified SOX4, CDKAL, and E2F3 as targets of this amplification and therefore potential oncogenes, but the more telomeric DEK gene too has been reported as overexpressed and amplified....
Autores principales: | Wu, Qiong, Hoffmann, Michèle J, Hartmann, Florian H, Schulz, Wolfgang A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131921/ https://www.ncbi.nlm.nih.gov/pubmed/15876350 http://dx.doi.org/10.1186/1476-4598-4-16 |
Ejemplares similares
-
6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer
por: Shen, He, et al.
Publicado: (2013) -
Case Report: Contiguous Xq22.3 Deletion Associated with ATS-ID Syndrome: From Genotype to Further Delineation of the Phenotype
por: Smetana, Jan, et al.
Publicado: (2021) -
Mapping of the chromosomal amplification 1p21-22 in bladder cancer
por: Scaravilli, Mauro, et al.
Publicado: (2014) -
A transcription map of the 6p22.3 reading disability locus identifying candidate genes
por: Londin, Eric R, et al.
Publicado: (2003) -
A 47,X,+t(X;X)(p22.3;p22.3)del(X)(p11.23q11.2),Y Klinefelter Variant with Morbid Obesity
por: Kim, Youngsook, et al.
Publicado: (2013)